In this cohort study of 941 infants enrolled in the Preterm Erythropoietin Neuroprotection Trial, mortality was lower and infants lived longer than in previous decades, and the most common cause of death was respiratory distress or failure. This evidence concerns the gene EPO and Respiratory distress.